Balance Sheet Laboratorios Farmaceuticos Rovi, S.A.

Stocks

ROVI

ES0157261019

Pharmaceuticals

Market Closed - BME Other stock markets 09:05:06 15/07/2026 pm IST			5-day change	1st Jan Change
53.80 ^EUR	+0.28%		-4.10%	-15.28%

13/05	Spanish stocks - Factors to watch on May 13	RE
09/05	Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026

78e4d4aae.aP78Qk3irZ3qACMTSccG3Tp5kvWjYnZC2jQprSXimOY.UYaVdHitnfqpTlZXJqBygg0ww5HTUQNv43Z61BGOwINckL0KAdTnqtlCcg

Published financial data: LABORATORIOS FARMACEUTICOS ROVI, S.A.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	65Cr	82Cr	83Cr	76Cr	74Cr
Total Revenues	65Cr	82Cr	83Cr	76Cr	74Cr
Cost of Goods Sold, Total	27Cr	31Cr	35Cr	30Cr	27Cr
Gross Profit	38Cr	51Cr	48Cr	47Cr	47Cr
Selling General & Admin Expenses, Total	10Cr	13Cr	15Cr	16Cr	16Cr
Depreciation & Amortization - (IS)	2.14Cr	2.29Cr	2.43Cr	2.8Cr	3.04Cr
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	-	-
Other Operating Expenses	7.34Cr	11Cr	9.25Cr	10Cr	11Cr
Other Operating Expenses, Total	20Cr	26Cr	26Cr	29Cr	30Cr
Operating Income	18Cr	25Cr	22Cr	18Cr	17Cr
Interest Expense, Total	-9L	-8L	-9L	-23.5L	-25.64L
Interest And Investment Income	68T	6T	7T	26T	5L
Net Interest Expenses	-8L	-8L	-9L	-23.24L	-20.59L
Income (Loss) On Equity Invest.	2L	2L	-1L	-1L	60T
Currency Exchange Gains (Loss)	-2L	-8L	-86T	3L	-2L
Other Non Operating Income (Expenses)	34.03L	39.32L	20.87L	11.54L	1.23Cr
EBT, Excl. Unusual Items	18Cr	26Cr	22Cr	18Cr	18Cr
Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	17.64L	-	-	-
Asset Writedown	-95T	-2T	-	-	-
Other Unusual Items	-15.81L	-	-	-	-
EBT, Incl. Unusual Items	18Cr	26Cr	22Cr	18Cr	18Cr
Income Tax Expense	2.96Cr	5.83Cr	5.01Cr	4.08Cr	4.29Cr
Earnings From Continuing Operations	15Cr	20Cr	17Cr	14Cr	14Cr
Net Income to Company	15Cr	20Cr	17Cr	14Cr	14Cr
Minority Interest	-	4T	36T	5T	78T
Net Income - (IS)	15Cr	20Cr	17Cr	14Cr	14Cr
Net Income to Common Incl Extra Items	15Cr	20Cr	17Cr	14Cr	14Cr
Net Income to Common Excl. Extra Items	15Cr	20Cr	17Cr	14Cr	14Cr
Per Share Items
Net EPS - Basic	2.76	3.73	3.2	2.67	2.75
Basic EPS - Continuing Operations	2.76	3.73	3.2	2.67	2.75
Basic Weighted Average Shares Outstanding	5.54Cr	5.35Cr	5.32Cr	5.12Cr	5.11Cr
Net EPS - Diluted	2.76	3.73	3.2	2.67	2.75
Diluted EPS - Continuing Operations	2.76	3.73	3.2	2.67	2.75
Diluted Weighted Average Shares Outstanding	5.54Cr	5.35Cr	5.32Cr	5.12Cr	5.11Cr
Normalized Basic EPS	2.08	3	2.59	2.17	2.24
Normalized Diluted EPS	2.08	3	2.59	2.17	2.24
Dividend Per Share	0.96	1.29	1.1	0.94	0.96
Payout Ratio	13.8	25.55	40.54	41.24	34.06
Supplemental Items
EBITDA	20Cr	27Cr	24Cr	20Cr	20Cr
EBITA	18Cr	26Cr	22Cr	18Cr	17Cr
EBIT	18Cr	25Cr	22Cr	18Cr	17Cr
EBITDAR	20Cr	27Cr	24Cr	20Cr	20Cr
Effective Tax Rate - (Ratio)	16.18	22.6	22.73	22.97	23.41
Total Current Taxes	2.19Cr	5.75Cr	5.08Cr	4.28Cr	4.46Cr
Total Deferred Taxes	71.02L	12.73L	-64T	-10.69L	-11.1L
Normalized Net Income	12Cr	16Cr	14Cr	11Cr	11Cr
Interest on Long-Term Debt	-	2L	3L	4L	3L
Non-Cash Pension Expense	8L	8L	8L	15.81L	11.24L
Supplemental Operating Expense Items
Advertising Expense	1.27Cr	2Cr	2.18Cr	2.17Cr	1.8Cr
Selling and Marketing Expenses	1.27Cr	2Cr	2.18Cr	2.17Cr	1.8Cr
Research And Development Expense From Footnotes	2.79Cr	2.43Cr	2.54Cr	2.62Cr	3.82Cr
Net Rental Expense, Total	8L	34.7L	24.62L	9L	13.82L
Imputed Operating Lease Interest Expense	82.3T	3L	3L	2L	2L
Imputed Operating Lease Depreciation	8L	31.46L	21.91L	7L	11.42L
Maintenance & Repair Expenses, Total	49.87L	71.84L	89.41L	1.06Cr	1.11Cr
Stock-Based Comp., SG&A Exp. (Total)	25.2L	-	-	-	-
Total Stock-Based Compensation	25.2L	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	9.9Cr	12Cr	2.53Cr	2.72Cr	9.8Cr
Short Term Investments	1L	89T	1L	8L	6L
Total Cash And Short Term Investments	9.91Cr	13Cr	2.54Cr	2.8Cr	9.86Cr
Accounts Receivable, Total	13Cr	16Cr	12Cr	11Cr	16Cr
Other Receivables	2.78Cr	2.11Cr	1.59Cr	1.26Cr	1.2Cr
Total Receivables	16Cr	18Cr	14Cr	13Cr	18Cr
Inventory	25Cr	31Cr	34Cr	33Cr	29Cr
Prepaid Expenses	17.91L	20.25L	27.27L	26.87L	31.88L
Other Current Assets, Total	23.31L	27.89L	27.44L	15.1L	15.93L
Total Current Assets	51Cr	62Cr	51Cr	49Cr	57Cr
Gross Property Plant And Equipment	37Cr	42Cr	48Cr	53Cr	60Cr
Accumulated Depreciation	-19Cr	-21Cr	-23Cr	-25Cr	-27Cr
Net Property Plant And Equipment	18Cr	22Cr	25Cr	29Cr	33Cr
Long-term Investments	20.66L	22.02L	6L	1.95Cr	1.92Cr
Goodwill	-	-	-	-	27.02L
Other Intangibles, Total	3.15Cr	2.91Cr	2.77Cr	2.82Cr	3.32Cr
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	38.5L	20.78L	23.43L	22.63L	31.99L
Deferred Charges Long-Term	70.45L	66.03L	61.61L	57.19L	-
Other Long-Term Assets, Total	65T	65T	65T	65T	-
Total Assets	73Cr	88Cr	80Cr	83Cr	96Cr
Liabilities
Accounts Payable, Total	9.94Cr	13Cr	11Cr	8.99Cr	8.48Cr
Accrued Expenses, Total	1.84Cr	3.43Cr	3.08Cr	3.32Cr	3.02Cr
Current Portion of Long-Term Debt	29.76L	82.66L	80.6L	1.78Cr	2.23Cr
Current Portion of Leases	34.41L	44.59L	51.25L	58.49L	63.59L
Current Income Taxes Payable	7L	-	52.55L	23.84L	44.02L
Unearned Revenue Current, Total	5.81Cr	12Cr	3.95Cr	52.48L	2.96Cr
Other Current Liabilities	74.2L	10L	15.28L	22.12L	35.76L
Total Current Liabilities	19Cr	29Cr	20Cr	16Cr	18Cr
Long-Term Debt	5.25Cr	4.6Cr	3.86Cr	8.05Cr	8.39Cr
Long-Term Leases	1.42Cr	1.34Cr	1.37Cr	1.02Cr	93.28L
Unearned Revenue Non Current	37.91L	33.19L	27.9L	27.46L	54.59L
Deferred Tax Liability Non Current	8L	7L	15.15L	4L	2L
Other Non Current Liabilities	-	-	-	-	2L
Total Liabilities	26Cr	36Cr	26Cr	25Cr	28Cr
Common Stock, Total	33.64L	32.41L	32.41L	30.74L	30.74L
Additional Paid In Capital	8.76Cr	8.76Cr	8.76Cr	8.76Cr	8.76Cr
Retained Earnings	45Cr	46Cr	56Cr	49Cr	58Cr
Treasury Stock	-6.61Cr	-2.76Cr	-11Cr	-55.45L	-51.74L
Comprehensive Income and Other	-2T	-8T	-21T	-23T	-54T
Total Common Equity	47Cr	52Cr	54Cr	57Cr	66Cr
Minority Interest	-	13.67L	41.07L	95.12L	1.1Cr
Total Equity	47Cr	52Cr	54Cr	58Cr	68Cr
Total Liabilities And Equity	73Cr	88Cr	80Cr	83Cr	96Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	5.49Cr	5.34Cr	5.18Cr	5.11Cr	5.11Cr
ECS Total Common Shares Outstanding	5.49Cr	5.34Cr	5.18Cr	5.11Cr	5.11Cr
Book Value / Share	8.59	9.74	10.41	11.18	12.99
Tangible Book Value	44Cr	49Cr	51Cr	54Cr	63Cr
Tangible Book Value Per Share	8.01	9.2	9.87	10.63	12.29
Total Debt	7.32Cr	7.22Cr	6.54Cr	11Cr	12Cr
Net Debt	-2.6Cr	-5.29Cr	4Cr	8.64Cr	2.32Cr
Debt Equivalent Oper. Leases	67.12L	2.78Cr	1.97Cr	68.8L	1.11Cr
Minority Interest, Total (Incl. Fin. Div)	-	13.67L	41.07L	95.12L	1.1Cr
Equity Method Investments, Total	19.94L	21.93L	6L	1.95Cr	1.92Cr
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	12Cr	16Cr	17Cr	11Cr	10Cr
Inventories - Work In Process, Total	5.04Cr	7.87Cr	8.05Cr	13Cr	12Cr
Inventories - Finished Goods, Total	7.01Cr	7.42Cr	8.81Cr	9.54Cr	6.65Cr
Land - (BS)	3.72Cr	4.51Cr	6.06Cr	7.48Cr	8.18Cr
Machinery, Total	28Cr	30Cr	37Cr	40Cr	45Cr
Full Time Employees	1.75T	1.99T	2.11T	1.93T	1.95T
Part Time Employees	-	-	-	67	95
Accumulated Allowance for Doubtful Accounts (Supple)	57T	5L	5L	3L	2L

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	15Cr	20Cr	17Cr	14Cr	14Cr
Depreciation & Amortization - CF	1.79Cr	1.94Cr	2.11Cr	2.5Cr	2.7Cr
Amortization of Goodwill and Intangible Assets - (CF)	24.22L	24.47L	23.73L	19.49L	17.67L
Depreciation & Amortization, Total	2.03Cr	2.18Cr	2.34Cr	2.69Cr	2.88Cr
Amortization of Deferred Charges, Total - (CF)	10.6L	10.34L	9L	10.93L	16.19L
(Gain) Loss From Sale Of Asset	-	-	-	43.94L	14T
(Gain) Loss on Sale of Investments - (CF)	-11.61L	-18.31L	2L	-81T	5L
Asset Writedown & Restructuring Costs	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-2L	-2L	1L	1L	-60T
Stock-Based Compensation (CF)	14.03L	-	-	-	-
Provision and Write-off of Bad Debts	-3L	40T	-38T	-79.74L	-3L
Other Operating Activities, Total	3.92Cr	7.4Cr	-4.73Cr	-3.21Cr	1.15Cr
Change In Accounts Receivable	-7.42Cr	-2.68Cr	1.95Cr	1.34Cr	-3.02Cr
Change In Inventories	-2.34Cr	-7.16Cr	-2.93Cr	1.19Cr	4.3Cr
Change In Accounts Payable	3.54Cr	4.17Cr	-2.39Cr	-1.64Cr	-77.49L
Change in Other Net Operating Assets	-17.78L	-2L	-7L	40T	-5L
Cash from Operations	15Cr	24Cr	11Cr	14Cr	19Cr
Capital Expenditure	-4.02Cr	-5.07Cr	-5.38Cr	-5.91Cr	-6.52Cr
Sale of Property, Plant, and Equipment	33T	78T	4L	37T	1L
Sale (Purchase) of Intangible assets	-7L	-7L	-13.93L	-31L	-26.03L
Investment in Marketable and Equity Securities, Total	-	-58.5L	12.88L	-1.9Cr	-34.63L
Other Investing Activities, Total	68T	6T	14.89L	1L	26.56L
Cash from Investing	-4.08Cr	-5.72Cr	-5.2Cr	-8.11Cr	-6.85Cr
Long-Term Debt Issued, Total	13.4L	13.99L	7L	9.7Cr	4.76Cr
Total Debt Issued	13.4L	13.99L	7L	9.7Cr	4.76Cr
Long-Term Debt Repaid, Total	-61.92L	-67.68L	-1.37Cr	-5.17Cr	-4.68Cr
Total Debt Repaid	-61.92L	-67.68L	-1.37Cr	-5.17Cr	-4.68Cr
Issuance of Common Stock	4.23Cr	7.78Cr	5.26Cr	4.19Cr	5.49Cr
Repurchase of Common Stock	-7.88Cr	-18Cr	-13Cr	-8.97Cr	-5.49Cr
Common Dividends Paid	-2.11Cr	-5.1Cr	-6.9Cr	-5.65Cr	-4.78Cr
Common & Preferred Stock Dividends Paid	-2.11Cr	-5.1Cr	-6.9Cr	-5.65Cr	-4.78Cr
Other Financing Activities, Total	-3L	10.8L	23.88L	36.41L	-8L
Cash from Financing	-6.27Cr	-15Cr	-16Cr	-5.54Cr	-4.78Cr
Net Change in Cash	4.59Cr	2.59Cr	-9.96Cr	18.64L	7.08Cr
Supplemental Items
Cash Interest Paid	3L	3L	4L	17.69L	22.98L
Cash Income Tax Paid (Refund)	2.39Cr	4.39Cr	4.09Cr	4.42Cr	4.19Cr
Levered Free Cash Flow	6.72Cr	14Cr	2.54Cr	4.46Cr	8.23Cr
Unlevered Free Cash Flow	6.77Cr	14Cr	2.6Cr	4.61Cr	8.39Cr
Change In Net Working Capital	2.88Cr	-63.79L	8.04Cr	3.14Cr	-1.31Cr
Net Debt Issued / Repaid	-48.52L	-53.69L	-1.29Cr	4.52Cr	8L

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	17.38	19.68	16.34	13.69	12.11
Return on Total Capital	22.89	27.88	22.81	17.12	14.49
Return On Equity %	36.25	40.24	31.98	24.33	22.33
Return on Common Equity	36.25	40.3	32.16	24.63	22.72
Margin Analysis
Gross Profit Margin %	58.56	62.67	58.27	61.24	63.43
SG&A Margin	15.92	15.9	17.72	20.72	21.58
EBITDA Margin %	30.55	33.18	28.69	26.14	26.3
EBITA Margin %	28.39	31.33	26.74	23.65	23.53
EBIT Margin %	28.02	31.03	26.46	23.4	23.29
Income From Continuing Operations Margin %	23.6	24.42	20.53	17.92	18.88
Net Income Margin %	23.6	24.42	20.53	17.92	18.89
Net Avail. For Common Margin %	23.6	24.42	20.53	17.92	18.89
Normalized Net Income Margin	17.76	19.58	16.61	14.54	15.42
Levered Free Cash Flow Margin	10.36	16.62	3.06	5.84	11.07
Unlevered Free Cash Flow Margin	10.44	16.69	3.13	6.04	11.28
Asset Turnover
Asset Turnover	0.99	1.01	0.99	0.94	0.83
Fixed Assets Turnover	3.85	4.12	3.54	2.83	2.41
Receivables Turnover (Average Receivables)	6.72	5.64	5.83	6.38	5.35
Inventory Turnover (Average Inventory)	1.14	1.1	1.07	0.89	0.88
Short Term Liquidity
Current Ratio	2.66	2.12	2.55	3.13	3.13
Quick Ratio	1.35	1.04	0.83	0.99	1.51
Operating Cash Flow to Current Liabilities	0.78	0.81	0.57	0.88	1.03
Days Sales Outstanding (Average Receivables)	54.34	64.73	62.65	57.36	68.27
Days Outstanding Inventory (Average Inventory)	320.87	333.24	342.64	412.88	414.76
Average Days Payable Outstanding	104.62	112.85	115.46	126.96	138.66
Cash Conversion Cycle (Average Days)	270.59	285.13	289.83	343.28	344.38
Long Term Solvency
Total Debt/Equity	15.53	13.84	12.04	19.67	18.04
Total Debt / Total Capital	13.45	12.16	10.74	16.44	15.28
LT Debt/Equity	14.17	11.4	9.61	15.6	13.8
Long-Term Debt / Total Capital	12.27	10.01	8.58	13.04	11.69
Total Liabilities / Total Assets	35.72	40.66	32.05	30.11	29.32
EBIT / Interest Expense	200.81	298.87	231.51	76.04	67.53
EBITDA / Interest Expense	223.25	324.59	256.23	87.5	78.74
(EBITDA - Capex) / Interest Expense	178.81	264.85	199.49	62.34	53.31
Total Debt / EBITDA	0.36	0.26	0.27	0.56	0.6
Net Debt / EBITDA	-0.13	-0.19	0.16	0.42	0.12
Total Debt / (EBITDA - Capex)	0.45	0.32	0.35	0.78	0.89
Net Debt / (EBITDA - Capex)	-0.16	-0.24	0.21	0.59	0.17
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	54.46	26.06	1.44	-7.93	-2.65
Gross Profit, 1 Yr. Growth %	60.18	34.91	-5.68	-3.23	0.83
EBITDA, 1 Yr. Growth %	121.13	38.04	-12.28	-16.13	-2.04
EBITA, 1 Yr. Growth %	137.34	40.32	-13.4	-18.57	-3.18
EBIT, 1 Yr. Growth %	142.57	40.85	-13.5	-18.58	-3.11
Earnings From Cont. Operations, 1 Yr. Growth %	150.71	30.43	-14.71	-19.63	2.55
Net Income, 1 Yr. Growth %	150.71	30.44	-14.69	-19.64	2.6
Normalized Net Income, 1 Yr. Growth %	149.14	40.22	-13.95	-19.4	3.2
Diluted EPS Before Extra, 1 Yr. Growth %	150.63	35.14	-14.25	-16.53	2.73
Accounts Receivable, 1 Yr. Growth %	104.94	23.44	-22.27	-7.81	42.23
Inventory, 1 Yr. Growth %	8.04	27.08	8.34	-2.37	-12.72
Net Property, Plant and Equip., 1 Yr. Growth %	16.98	18.58	17.68	13	15.39
Total Assets, 1 Yr. Growth %	27.55	19.93	-8.97	4.02	14.86
Tangible Book Value, 1 Yr. Growth %	29.34	11.7	4.23	6.28	16.81
Common Equity, 1 Yr. Growth %	26.03	10.41	3.73	6.05	16.15
Cash From Operations, 1 Yr. Growth %	218.8	58.99	-52.34	22.1	35.29
Capital Expenditures, 1 Yr. Growth %	2.24	26.11	6.06	9.9	10.3
Levered Free Cash Flow, 1 Yr. Growth %	-657.51	105.33	-81.34	75.96	83.48
Unlevered Free Cash Flow, 1 Yr. Growth %	-695.3	104.38	-80.98	77.6	82.02
Dividend Per Share, 1 Yr. Growth %	150.68	35.39	-14.69	-15.28	2.6
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	30.43	39.54	13.08	-3.36	-5.33
Gross Profit, 2 Yr. CAGR %	34.03	47	12.81	-4.46	-1.22
EBITDA, 2 Yr. CAGR %	89.05	74.01	10.04	-14.23	-9.36
EBITA, 2 Yr. CAGR %	103.03	81.71	10.23	-16.03	-11.21
EBIT, 2 Yr. CAGR %	107.93	84.03	10.37	-16.08	-11.18
Earnings From Cont. Operations, 2 Yr. CAGR %	97.43	80.84	5.48	-17.2	-9.21
Net Income, 2 Yr. CAGR %	97.43	80.84	5.49	-17.2	-9.2
Normalized Net Income, 2 Yr. CAGR %	108.93	86.1	9.84	-16.72	-8.8
Diluted EPS Before Extra, 2 Yr. CAGR %	97.03	83.94	7.71	-15.4	-7.4
Accounts Receivable, 2 Yr. CAGR %	34.58	59.05	-2.04	-15.34	14.51
Inventory, 2 Yr. CAGR %	24.33	17.18	17.34	2.85	-7.69
Net Property, Plant and Equip., 2 Yr. CAGR %	17.52	17.77	18.13	15.32	14.19
Total Assets, 2 Yr. CAGR %	19.72	23.68	4.49	-2.69	9.31
Tangible Book Value, 2 Yr. CAGR %	24.12	20.2	7.9	5.25	10.84
Common Equity, 2 Yr. CAGR %	20.87	17.96	7.02	4.88	10.99
Cash From Operations, 2 Yr. CAGR %	306.49	125.14	-12.95	-23.71	28.53
Capital Expenditures, 2 Yr. CAGR %	24.61	13.55	15.65	7.96	10.1
Levered Free Cash Flow, 2 Yr. CAGR %	2.24	235.84	-38.1	-42.7	80.14
Unlevered Free Cash Flow, 2 Yr. CAGR %	3	246.26	-37.65	-41.88	79.8
Dividend Per Share, 2 Yr. CAGR %	133.61	84.23	7.47	-14.99	-6.77
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	28.85	28.95	25.47	5.59	-3.12
Gross Profit, 3 Yr. CAGR %	30.46	34.32	26.79	7.18	-2.73
EBITDA, 3 Yr. CAGR %	94.37	69.78	38.49	0.52	-10.34
EBITA, 3 Yr. CAGR %	119.4	78.99	41.93	-0.35	-11.95
EBIT, 3 Yr. CAGR %	125.39	82.08	43.09	-0.27	-11.96
Earnings From Cont. Operations, 3 Yr. CAGR %	104.52	71.95	40.76	-3.66	-11.08
Net Income, 3 Yr. CAGR %	104.52	71.95	40.77	-3.66	-11.07
Normalized Net Income, 3 Yr. CAGR %	122.73	82.4	43.91	-0.93	-10.55
Diluted EPS Before Extra, 3 Yr. CAGR %	99.24	73.7	42.68	-1.06	-9.74
Accounts Receivable, 3 Yr. CAGR %	36.53	30.76	25.28	-4	0.64
Inventory, 3 Yr. CAGR %	37.29	25.24	14.15	10.36	-2.63
Net Property, Plant and Equip., 3 Yr. CAGR %	23.78	17.87	17.74	16.39	15.34
Total Assets, 3 Yr. CAGR %	22.08	19.79	11.67	4.33	2.84
Tangible Book Value, 3 Yr. CAGR %	18.94	19.84	14.62	7.36	8.59
Common Equity, 3 Yr. CAGR %	17.89	17.28	13.01	6.69	8.51
Cash From Operations, 3 Yr. CAGR %	159.71	197.28	34.18	-2.55	-7.66
Capital Expenditures, 3 Yr. CAGR %	34.88	25.11	11	13.7	8.74
Levered Free Cash Flow, 3 Yr. CAGR %	42.77	28.36	28.15	-12.32	-15.4
Unlevered Free Cash Flow, 3 Yr. CAGR %	44.1	28.8	31.63	-11.62	-14.97
Dividend Per Share, 3 Yr. CAGR %	128.78	94.77	42.53	-0.72	-9.49
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	19.59	24.29	22.3	14.9	12.1
Gross Profit, 5 Yr. CAGR %	20.45	25.92	23.09	17.21	14.74
EBITDA, 5 Yr. CAGR %	43.45	60.57	54.56	29.2	16.89
EBITA, 5 Yr. CAGR %	50.3	72.55	66.31	32.24	17.65
EBIT, 5 Yr. CAGR %	51.54	75.64	69.1	33.57	18.24
Earnings From Cont. Operations, 5 Yr. CAGR %	42.46	63.21	56.93	28.36	18.11
Net Income, 5 Yr. CAGR %	42.46	63.21	56.93	28.37	18.13
Normalized Net Income, 5 Yr. CAGR %	50.48	71	67.58	33.3	19.91
Diluted EPS Before Extra, 5 Yr. CAGR %	39.17	60.55	55.75	30.3	20.02
Accounts Receivable, 5 Yr. CAGR %	23.42	31.26	19.55	9.89	20.86
Inventory, 5 Yr. CAGR %	29.51	32.81	28.93	15.75	4.86
Net Property, Plant and Equip., 5 Yr. CAGR %	17.02	19.34	21.49	16.84	16.31
Total Assets, 5 Yr. CAGR %	20.55	24.11	14.71	10.23	10.72
Tangible Book Value, 5 Yr. CAGR %	21.97	23.19	14.39	13.77	13.09
Common Equity, 5 Yr. CAGR %	20.76	22.09	13.41	12.15	12.2
Cash From Operations, 5 Yr. CAGR %	26.84	67.47	67.73	72.54	31.89
Capital Expenditures, 5 Yr. CAGR %	32.96	27.71	26.83	17.95	10.64
Levered Free Cash Flow, 5 Yr. CAGR %	27.31	76.97	1.9	-7.03	46.85
Unlevered Free Cash Flow, 5 Yr. CAGR %	26.8	80.12	2.77	-6.31	49.11
Dividend Per Share, 5 Yr. CAGR %	39.18	60.71	69.11	39.8	20.27